Synthesis and Determination of Thermal Decomposition of Biological Active Arene Ruthenium Compound Containing Bisbenzimidazole Linker

Abstract

In this study, [Ru₄(p-cymene)₄(μ-NՈN)₂(μ₄-OOՈOO)₂][CF₃SO₃)₄] (NՈN = Butylene-1,4-bisbenzimidazole (bbim)) biologically active tetranuclear arene complex compound, reacting Ru₂(p-cymene)₂(μ₄- OOՈOO) Cl₂  (OOՈOO = 5,8-dioxido-1,4-naphtoquinonato (donq)) with silver trifluoromethanesulfonate, followed by the addition of the corresponding NՈN linkers. The biologically active arene ruthenium compound was characterized by standard techniques including IR, UV-VIS, ¹H NMR, ¹³C NMR spectroscopy and ESI-MS spectrometry. Thermal decomposition measurement data of arene ruthenium compound were examined. These measurements were made by Thermogravimetric analysis (TGA) and Differential thermal analysis (DTA) techniques.

Keywords

• Arene ruthenium,Bisbenzimidazole,Supramolecular chemistry,Thermal decomposition

Bisbenzimidazol Bağlayıcı İçeren Biyolojik Aktif Aren Rutenyum Bileşiğinin Sentezi ve Termal Bozunmasının Belirlenmesi

Abstract

Bu çalışmada [Ru₄(p-cymene)₄(μ₂-NՈN)₂(μ₄-OOՈOO)₂][CF₃SO₃)₄] (NՈN = Bütilen-1,4-bisbenzimidazol (bbim)) genel formülüne sahip biyolojik aktif tetranükleer aren rutenyum kompleks bileşiği, Ru₂(p-cymene)₂ (μ₄-OOՈOO)Cl₂ (OOՈOO = 5,8-dioxido-1,4-naphtoquinonato (donq))'nun gümüş triflorometansülfonat ile reaksiyona sokulması, ardından karşılık gelen NՈN bağlayıcılarının eklenmesi ile hazırlanmıştır. Biyolojik aktif aren rutenyum bileşiği IR, UV-VIS, ¹H, ¹³C NMR spektroskopisi ve ESI-MS spektrometresi dahil standart tekniklerle karakterize edildi. Aren rutenyum bileşiğinin termal bozunma ölçüm verileri incelendi. Bu ölçümler Termogravimetrik analiz (TGA) ve Diferansiyel termal analiz (DTA) teknikleri ile yapıldı.

Keywords

• Aren rutenyum,Bisbenzimidazol,Supramoleküler kimya,Termal bozulma

References

1. [1] B. Rosenbeng, L. Vancamp, J. E. Trosko, and V. H. Mansour, “Nature,” Nature, vol. 222, pp. 285–286, 1969.
2. [2] E. Orhan, A. Garci, B. Therrien, "Coordination-driven self-assembly of arene ruthenium metalla-rectangles," Inorganica Chimica Acta, vol. 461, pp. 78–83, 2017.
3. [3] E. Orhan, A. Garci, T. Riedel, P. J. Dyson, B. Therrien, " Cytotoxicity of arene ruthenium metalla-rectangles incorporating bis-pyridyl diimide linkers," Journal of Organometallic Chemistry, vol. 815-816, pp. 53-58, 2016.
4. [4] M. Galanski, M. A. Jakupec, and B. K. Keppler, “Update of the Preclinical Situation of Anticancer Platinum Complexes : Novel Design Strategies and Innovative Analytical Approaches,” Curr. Med. Chem., vol. 12, pp. 2075–2094, 2005.
5. [5] E. Orhan, A. Garci, T. Riedel, M. Saudani, P. J. Dyson, B. Therrien, "Cytotoxic double arene ruthenium metalla-cycles that overcome cisplatin resistance," Journal of Organometallic Chemistry, vol. 803, pp. 39-44, 2016.
6. [6] C. S. Allardyce and P. J. Dyson, “Ruthenium in Medicine : Current Clinical Uses and Future Prospects,” Platin. Met. Rev., vol. 45, no. 2, pp. 62–69, 2001.
7. [7] I. Kostova, “Ruthenium Complexes as Anticancer Agents,” Curr. Med. Chem., vol. 13, pp. 1085–1107, 2006.
8. [8] C. S. Allardyce, A. Dorcier, C. Scolaro, and P. J. Dyson, “Development of organometallic (organo-transition metal) pharmaceuticals,” Bioorganometallic Chem., vol. 19, pp. 1–10, 2005.

9. [9] E. Orhan, A. Garci, B. Therrien, "Flexible arene ruthenium metalla-prisms," Inorganica Chimica Acta, vol. 438, pp. 5–9, 2015.
10. [10] A. Garci, J. P. Mbakidi, V. Chaleix, V. Sol, E. Orhan, B. Therrien, "Tunable Arene Ruthenium Metallaprisms to Transport, Shield, and Release Porphin in Cancer Cells," Organometallics, vol. 34, pp. 4138−4146, 2015.
11. [11] A. Garci, A. A. Dobrov, T. Riedel, E. Orhan, P. J. Dyson, V. B. Arion, B. Therrien, "Strategy to optimize the biological activity of arene ruthenium metalla-assemblies," Organometallics, vol. 33, pp. 3813−3822, 2014.
12. [12] A. A. Hummer et al., “X-ray absorption near edge structure spectroscopy to resolve the in vivo chemistry of the redox-active Indazolium trans - [ tetrachlorobis ( 1H- indazole ) ruthenate ( III )] ( KP1019 ),” J. Med. Chem., vol. 56, pp. 1182, 2013.
13. [13] G. Tamasi et al., “Synthesis , spectroscopic and DFT structural characterization of two novel ruthenium ( III ) oxicam complexes . In vivo evaluation of anti-in fl ammatory and gastric damaging activities,” J. Inorg. Biochem., vol. 134, pp. 25–35, 2014.
14. [14] G. Süss-Fink, “Water-soluble arene ruthenium complexes : From serendipity to catalysis and drug design,” J. Organomet. Chem., vol. 751, pp. 2–19, 2014.
15. [15] H. Küçükbay, S. Günal, E. Orhan, R. Durmaz, "Synthesis and antimicrobial activities of some transition metal benzimidazole complexes," Asian Journal of Chemistry, vol. 22, pp. 7376–7382, 2010.
16. [16] H. Küçükbay, R. Durmaz, E. Orhan, S. Günal, "Synthesis, antibacterial and antifungal activities of electron-rich olefins derived benzimidazole compounds," Farmaco, vol. 58, pp. 431–437, 2003.
17. [17] Ü. Ergun, "ONO Ve ONNO Tipindeki Schiff Bazlarının Geçiş Metalleri Komplekslerinin Termal Bozunma Tepkimelerinde Kinetik Parametrelerinin Belirlenmesi ve Bazı Koordinasyon Bağ Enerjilerinin Hesaplanması, Doktora Tezi, Kimya ABD, Ankara Üniversitesi, Ankara, Türkiye, 2009.
18. [18] M. A. Bennett and A. K. Smith, “Arene Ruthenium ( II ) Complexes formed by Dehydrogenation of cyclo-hexadienes with ruthenium( III) trichloride,” pp. 233–241, 1974.
19. [19] N. P. E. Barry and B. Therrien, “Host-guest Chemistry in the Hexanuclear (arene)Ruthenium metalla-prismatic cage [Ru6(p-cymene)6(tpt)2(dhnq) 3]6+,” Eur. J. Inorg. Chem., vol. 6, pp. 4695–4700, 2009.
20. [20] H. Küçükbay, R. Durmaz, N. Okuyucu, S. Günal, and C. Kazaz, “ArzneimForschDrugRes Synthesis and Antibacterial Activities of New Bis-benzimidazoles,” Arzneim.-Forsch./Drug Res., vol. 54, no. 1, pp. 64–68, 2004.